Download PDF
Semin Liver Dis 2008; 28(1): 070-080
DOI: 10.1055/s-2008-1040322
© Thieme Medical Publishers

Hepatic Encephalopathy

Juan Córdoba1 , Beatriz Mínguez1
  • 1Servei de Medicina Interna-Hepatologia, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain
Further Information

Publication History

Publication Date:
22 February 2008 (online)

    Permissions and Reprints

ABSTRACT

Hepatic encephalopathy is a severe complication of cirrhosis that is related to the effects of ammonia. Analysis of interorgan ammonia trafficking has identified an important role of skeletal muscle in ammonia removal and has highlighted the importance of the nutritional status. Ammonia causes neurotransmitter abnormalities and induces injury to astrocytes that is partially mediated by oxidative stress. These disturbances lead to astrocyte swelling and brain edema, which appear to be involved in the pathogenesis of neurological manifestations. Inflammatory mediators worsen brain disturbances. New methods for assessing hepatic encephalopathy include clinical scales, neuropsychological tests, imaging of portal-systemic circulation, and magnetic resonance of the brain. Reappraisal of current therapy indicates the need for performing placebo-controlled trials and the lack of evidence for administering diets with restricted protein content. Liver transplant should be considered in selected patients with hepatic encephalopathy. Future prospects include new drugs that decrease plasma ammonia, measures to reduce brain edema, and liver-support devices.

KEYWORDS

Hepatic encephalopathy - ammonia - pathogenesis - diagnostic methods - therapy

REFERENCES

  • 1 Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A T. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.  Hepatology. 2002;  35 716-721
    CrossrefPubMedGoogle Scholar
  • 2 Conn H O. Portal-systemic shunting and portal-systemic encephalopathy: a predictable relationship.  Hepatology. 1995;  22 365-367
    PubMedGoogle Scholar
  • 3 Shawcross D L, Damink S W, Butterworth R F, Jalan R. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same.  Metab Brain Dis. 2005;  20 169-179
    CrossrefPubMedGoogle Scholar
  • 4 Huizenga J R, Gips C H, Tangerman A. The contribution of various organs to ammonia formation: a review of factors determining the arterial ammonia concentration.  Ann Clin Biochem. 1996;  33 23-30
    PubMedGoogle Scholar
  • 5 Romero-Gomez M. Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy.  Metab Brain Dis. 2005;  20 319-325
    CrossrefPubMedGoogle Scholar
  • 6 Romero-Gomez M, Ramos-Guerrero R, Grande L et al.. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy.  J Hepatol. 2004;  41 49-54
    CrossrefPubMedGoogle Scholar
  • 7 Hawkins R A, Jessy J, Mans A M, Chedid A, DeJoseph M R. Neomycin reduces the intestinal production of ammonia from glutamine.  Adv Exp Med Biol. 1994;  368 125-134
    PubMedGoogle Scholar
  • 8 Albrecht J, Norenberg M D. Glutamine: a Trojan horse in ammonia neurotoxicity.  Hepatology. 2006;  44 788-794
    CrossrefPubMedGoogle Scholar
  • 9 Olde Damink S W, Jalan R, Redhead D N, Hayes P C, Deutz N E, Soeters P B. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.  Hepatology. 2002;  36 1163-1171
    CrossrefPubMedGoogle Scholar
  • 10 Kondrup J, Nielsen K, Juul A. Effect of long-term refeeding on protein metabolism in patients with cirrhosis of the liver.  Br J Nutr. 1997;  77 197-212
    CrossrefPubMedGoogle Scholar
  • 11 Olde Damink S W, Jalan R, Deutz N E et al.. Isoleucine infusion during “simulated” upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients.  Hepatology. 2007;  45 560-568
    CrossrefPubMedGoogle Scholar
  • 12 Mendenhall C L, Moritz T E, Roselle G A et al.. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275.  JPEN J Parenter Enteral Nutr. 1995;  19 258-265
    CrossrefPubMedGoogle Scholar
  • 13 Córdoba J, López-Hellin J, Planas M et al.. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.  J Hepatol. 2004;  41 38-43
    CrossrefPubMedGoogle Scholar
  • 14 Plauth M, Merli M, Weimann A, Ferenci P, Mueller M J. ESPEN guidelines for nutrition in liver disease and transplantation.  Clin Nutr. 1997;  16 43-55
    PubMedGoogle Scholar
  • 15 Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.  Biochem Biophys Res Commun. 2004;  313 405-409
    CrossrefPubMedGoogle Scholar
  • 16 Marchesini G, Bianchi G, Merli M et al.. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind randomized trial.  Gastroenterology. 2003;  124 1792-1801
    CrossrefPubMedGoogle Scholar
  • 17 Marchesini G, Dioguardi F S, Bianchi G P et al.. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: a randomized double-blind casein-controlled trial.  J Hepatol. 1990;  11 92-101
    CrossrefPubMedGoogle Scholar
  • 18 Olde Damink S WM, Jalan R, Deutz N E et al.. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis.  Hepatology. 2003;  37 1277-1285
    CrossrefPubMedGoogle Scholar
  • 19 Jalan R, Kapoor D. Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver.  Gut. 2003;  52 1041-1045
    CrossrefPubMedGoogle Scholar
  • 20 Lockwood A H. Blood ammonia levels and hepatic encephalopathy.  Metab Brain Dis. 2004;  19(3-4) 345-349
    CrossrefPubMedGoogle Scholar
  • 21 Kramer L, Tribl B, Gendo A et al.. Partial pressure of ammonia versus ammonia in hepatic encephalopathy.  Hepatology. 2000;  31 30-34
    CrossrefPubMedGoogle Scholar
  • 22 Nicolao F, Efrati C, Masini A, Merli M, Attili A F, Riggio O. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy.  J Hepatol. 2003;  38 441-446
    PubMedGoogle Scholar
  • 23 Ott P, Larsen F S. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal.  Neurochem Int. 2004;  44 185-198
    CrossrefPubMedGoogle Scholar
  • 24 Lockwood A H, Yap E W, Wong W H. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.  J Cereb Blood Flow Metab. 1991;  11 337-341
    PubMedGoogle Scholar
  • 25 Watanabe A. Portal-systemic encephalopathy in non-cirrhotic patients: classification of clinical types, diagnosis and treatment.  J Gastroenterol Hepatol. 2000;  15 969-979
    CrossrefPubMedGoogle Scholar
  • 26 Ortiz M, Córdoba J, Alonso J et al.. Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts.  J Hepatol. 2004;  40 552-557
    CrossrefPubMedGoogle Scholar
  • 27 Blei A T. Infection, inflammation and hepatic encephalopathy, synergism redefined.  J Hepatol. 2004;  40 327-330
    CrossrefPubMedGoogle Scholar
  • 28 Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure.  Hepatology. 2000;  32 734-739
    CrossrefPubMedGoogle Scholar
  • 29 Vaquero J, Polson J, Chung C et al.. Infection and the progression of hepatic encephalopathy in acute liver failure.  Gastroenterology. 2003;  125 755-764
    CrossrefPubMedGoogle Scholar
  • 30 Häussinger D, Schliess F. Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy.  Neurochem Int. 2005;  47;  (1-2) 64-70
    CrossrefPubMedGoogle Scholar
  • 31 Pedersen H R, Ring-Larsen H, Olsen N V, Larsen F S. Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anaesthetised with pentobarbital.  J Hepatol. 2007;  47 245-252
    CrossrefPubMedGoogle Scholar
  • 32 Jalan R, Bernuau J. Induction of cerebral hyperemia by ammonia plus endotoxin: does hyperammonemia unlock the blood-brain barrier?.  J Hepatol. 2007;  47 168-171
    CrossrefPubMedGoogle Scholar
  • 33 Such J, Frances R, Munoz C et al.. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites.  Hepatology. 2002;  36 135-141
    CrossrefPubMedGoogle Scholar
  • 34 Butterworth R F. Pathophysiology of hepatic encephalopathy: a new look at ammonia.  Metab Brain Dis. 2002;  17 221-227
    CrossrefPubMedGoogle Scholar
  • 35 Norenberg M D. Astrocytic-ammonia interactions in hepatic encephalopathy.  Semin Liver Dis. 1996;  16 245-253
    PubMedGoogle Scholar
  • 36 Butterworth R F. Hepatic encephalopathy and brain edema in acute hepatic failure: does glutamate play a role?.  Hepatology. 1997;  25 1032-1033
    CrossrefPubMedGoogle Scholar
  • 37 Vogels B A, Maas M A, Daalhuisein J, Quack G, Chamuleau R A. Memantine, a non-competitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.  Hepatology. 1997;  25 820-827
    CrossrefPubMedGoogle Scholar
  • 38 Ahboucha S, Layrargues G P, Mamer O, Butterworth R F. Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy.  Ann Neurol. 2005;  58 169-170
    CrossrefPubMedGoogle Scholar
  • 39 Norenberg M D. Oxidative and nitrosative stress in ammonia neurotoxicity.  Hepatology. 2003;  37 245-248
    CrossrefPubMedGoogle Scholar
  • 40 Chatauret N, Zwingmann C, Rose C, Leibfritz D, Butterworth R F. Effects of hypothermia on brain glucose metabolism in acute liver failure: a H/C-nuclear magnetic resonance study.  Gastroenterology. 2003;  125 815-824
    CrossrefPubMedGoogle Scholar
  • 41 Wendon J A, Harrison P M, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure.  Hepatology. 1994;  19 1407-1413
    CrossrefPubMedGoogle Scholar
  • 42 Schliess F, Gorg B, Häussinger D. Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm.  Biol Chem. 2006;  387(10-11) 1363-1370
    CrossrefPubMedGoogle Scholar
  • 43 Norenberg M D, Baker L, Norenberg L O. Ammonia-induced astrocyte swelling in primary cultures.  Neurochem Res. 1991;  16 833-836
    CrossrefPubMedGoogle Scholar
  • 44 Gorg B, Foster N, Reinehr R et al.. Benzodiazepine-induced protein tyrosine nitration in rat astrocytes.  Hepatology. 2003;  37 334-342
    CrossrefPubMedGoogle Scholar
  • 45 Häussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?.  J Hepatol. 2000;  32 1035-1038
    CrossrefPubMedGoogle Scholar
  • 46 Amodio P, Gatta A. Neurophysiological investigation of hepatic encephalopathy.  Metab Brain Dis. 2005;  20 369-379
    CrossrefPubMedGoogle Scholar
  • 47 Inouye S K, van Dyck C H, Alessi C A, Balkin S, Siegal A P, Horwitz R I. Clarifying confusion-the confusion assessment method: a new method for detection of delirium.  Ann Intern Med. 1990;  113 941-948
    CrossrefPubMedGoogle Scholar
  • 48 Hassanein T I, Hilsabeck R C, Perry W. Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA).  Dig Dis Sci. 2008;  53 529-538
    CrossrefPubMedGoogle Scholar
  • 49 Ortiz M, Córdoba J, Doval E et al.. Development of a clinical hepatic encephalopathy staging scale.  Aliment Pharmacol Ther. 2007;  26 859-867
    PubMedGoogle Scholar
  • 50 Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations.  J Hepatol. 2005;  42(suppl 1) S45-S53
    CrossrefPubMedGoogle Scholar
  • 51 Weissenborn K, Ennen J C, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy.  J Hepatol. 2001;  34 768-773
    CrossrefPubMedGoogle Scholar
  • 52 Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy.  Hepatology. 2002;  35 357-366
    CrossrefPubMedGoogle Scholar
  • 53 Romero-Gomez M, Córdoba J, Jover R et al.. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.  Hepatology. 2007;  45 879-885
    CrossrefPubMedGoogle Scholar
  • 54 Hassoun Z, Deschenes M, Lafortune M et al.. Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy.  Am J Gastroenterol. 2001;  96 1205-1209
    CrossrefPubMedGoogle Scholar
  • 55 Blei A T. Hepatic encephalopathy in the age of TIPS.  Hepatology. 1994;  20(1 Pt 1) 249-252
    PubMedGoogle Scholar
  • 56 Riggio O, Efrati C, Catalano C et al.. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.  Hepatology. 2005;  42 1158-1165
    CrossrefPubMedGoogle Scholar
  • 57 Córdoba J, Hinojosa C, Sampedro F et al.. Usefulness of magnetic resonance spectroscopy for diagnosis of hepatic encephalopathy in a patient with relapsing confusional syndrome.  Dig Dis Sci. 2001;  46 2451-2455
    CrossrefPubMedGoogle Scholar
  • 58 Ohnishi K, Saito M, Sato S et al.. Direction of splenic venous flow assessed by pulsed Doppler flowmetry in patients with a large splenorenal shunt: relation to spontaneous hepatic encephalopathy.  Gastroenterology. 1985;  89 180-185
    PubMedGoogle Scholar
  • 59 Uflacker R, Silva A, d'Albuquerque L A, Piske R L, Mourao G S. Chronic portosystemic encephalopathy: embolization of portosystemic shunts.  Radiology. 1987;  165 721-725
    PubMedGoogle Scholar
  • 60 Mínguez B, Garcia-Pagan J C, Bosch J et al.. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.  Hepatology. 2006;  43 707-714
    CrossrefPubMedGoogle Scholar
  • 61 Francoz C, Belghiti J, Vilgrain V et al.. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.  Gut. 2005;  54 691-697
    CrossrefPubMedGoogle Scholar
  • 62 Kulisevsky J, Pujol J, Balanzo J et al.. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations.  Hepatology. 1992;  16 1382-1388
    CrossrefPubMedGoogle Scholar
  • 63 Rose C, Butterworth R F, Zayed J et al.. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.  Gastroenterology. 1999;  117 640-644
    CrossrefPubMedGoogle Scholar
  • 64 Spahr L, Butterworth R F, Fontaine S et al.. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms.  Hepatology. 1996;  24 1116-1120
    CrossrefPubMedGoogle Scholar
  • 65 Kreis R, Ross B D, Farrow N A, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy.  Radiology. 1992;  182 19-27
    PubMedGoogle Scholar
  • 66 Lee J H, Seo D W, Lee Y-S et al.. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.  Am J Gastroenterol. 1999;  94 2206-2213
    CrossrefPubMedGoogle Scholar
  • 67 Córdoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L L et al.. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.  J Hepatol. 2001;  35 598-604
    CrossrefPubMedGoogle Scholar
  • 68 Lodi R, Tonon C, Stracciari A et al.. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics.  Neurology. 2004;  62 762-766
    PubMedGoogle Scholar
  • 69 Kale R A, Gupta R K, Saraswat V A et al.. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy.  Hepatology. 2006;  43 698-706
    CrossrefPubMedGoogle Scholar
  • 70 Córdoba J, Blei A T. Brain edema and hepatic encephalopathy.  Semin Liver Dis. 1996;  16 271-280
    PubMedGoogle Scholar
  • 71 Rovira A, Mínguez B, Aymerich F X et al.. Decreased white matter lesion volume and improved cognitive function after liver transplantation.  Hepatology. 2007;  46 1485-1490
    CrossrefPubMedGoogle Scholar
  • 72 Córdoba J, Blei A T. Treatment of hepatic encephalopathy.  Am J Gastroenterol. 1997;  92 1429-1439
    PubMedGoogle Scholar
  • 73 Shawcross D, Jalan R. Dispelling myths in the treatment of hepatic encephalopathy.  Lancet. 2005;  365 431-433
    PubMedGoogle Scholar
  • 74 Als-Nielsen B, Gluud L L, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.  BMJ. 2004;  328 1046
    CrossrefPubMedGoogle Scholar
  • 75 Blei A T. Treatment of hepatic encephalopathy.  Lancet. 2005;  365 1383-1384
    PubMedGoogle Scholar
  • 76 Curioso W H, Monkemuller K E. Neomycin should not be used to treat hepatic encephalopathy.  BMJ. 2001;  323 233
    CrossrefPubMedGoogle Scholar
  • 77 Riordan S M, Williams R. Treatment of hepatic encephalopathy.  N Engl J Med. 1997;  337 473-479
    CrossrefPubMedGoogle Scholar
  • 78 Soulsby C T, Morgan M Y. Dietary management of hepatic encephalopathy in cirrhotic patients: survey of current practice in United Kingdom.  BMJ. 1999;  318 1391
    CrossrefPubMedGoogle Scholar
  • 79 Plauth M, Cabre E, Riggio O et al.. ESPEN guidelines on enteral nutrition: liver disease.  Clin Nutr. 2006;  25 285-294
    CrossrefPubMedGoogle Scholar
  • 80 Mullen K D, Weber Jr F L. Role of nutrition in hepatic encephalopathy.  Semin Liver Dis. 1991;  11 292-304
    Article in Thieme ConnectPubMedGoogle Scholar
  • 81 Kondrup J, Muller M J. Energy and protein requirements of patients with chronic liver disease.  J Hepatol. 1997;  27 239-247
    CrossrefPubMedGoogle Scholar
  • 82 Felipo V, Miñana D, Grisolia S. Control of urea synthesis and ammonia utilization in protein deprivation and refeeding.  Arch Biochem Biophys. 1991;  285 351-356
    CrossrefPubMedGoogle Scholar
  • 83 Bustamante J, Rimola A, Ventura P et al.. Prognostic significance of hepatic encephalopathy in patients with cirrhosis.  J Hepatol. 1999;  30 890-895
    CrossrefPubMedGoogle Scholar
  • 84 Murray K F, Carithers Jr R L. AASLD practice guidelines: evaluation of the patient for liver transplantation.  Hepatology. 2005;  41 1407-1432
    CrossrefPubMedGoogle Scholar
  • 85 Stewart C A, Malinchoc M, Kim W R, Kamath P S. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease.  Liver Transpl. 2007;  13 1366-1371
    CrossrefPubMedGoogle Scholar
  • 86 Weissenborn K, Tietge U J, Bokemeyer M et al.. Liver transplantation improves hepatic myelopathy: evidence by three cases.  Gastroenterology. 2003;  124 346-351
    CrossrefPubMedGoogle Scholar
  • 87 Larsen F S, Ranek L, Hansen B A, Kirkegaard P. Chronic portosystemic hepatic encephalopathy refractory to medical treatment successfully reversed by liver transplantation.  Transpl Int. 1995;  8 246-247
    CrossrefPubMedGoogle Scholar
  • 88 Zeneroli M L, Cioni G, Crisi G, Vezzelli C, Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study.  Magn Reson Imaging. 1991;  9 295-302
    CrossrefPubMedGoogle Scholar
  • 89 Mechtcheriakov S, Graziadei I W, Mattedi M et al.. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation.  Liver Transpl. 2004;  10 77-83
    CrossrefPubMedGoogle Scholar
  • 90 Rose C, Jalan R. Is minimal hepatic encephalopathy completely reversible following liver transplantation?.  Liver Transpl. 2004;  10 84-87
    CrossrefPubMedGoogle Scholar
  • 91 Amodio P, Biancardi A, Montagnese S et al.. Neurological complications after orthotopic liver transplantation.  Dig Liver Dis. 2007;  39 740-747
    CrossrefPubMedGoogle Scholar
  • 92 Pujol A, Graus F, Rimola A et al.. Predictive factors of in-hospital CNS complications following liver transplantation.  Neurology. 1994;  44 1226-1230
    PubMedGoogle Scholar
  • 93 Kanwal F, Chen D, Ting L et al.. A model to predict the development of mental status changes of unclear cause after liver transplantation.  Liver Transpl. 2003;  9 1312-1319
    CrossrefPubMedGoogle Scholar
  • 94 Plauth M, Raible A, Vieillard-Baron D, Bauder-Gross D, Hartmann F. Is glutamine essential for the maintenance of intestinal function? A study in the isolated perfused rat small intestine.  Int J Colorectal Dis. 1999;  14 86-94
    CrossrefPubMedGoogle Scholar
  • 95 Kircheis G, Nilius R, Held C et al.. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.  Hepatology. 1997;  25 1351-1360
    CrossrefPubMedGoogle Scholar
  • 96 Jalan R, Wright G, Davies N A, Hodges S J. L-ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.  Med Hypotheses. 2007;  69 1064-1069
    CrossrefPubMedGoogle Scholar
  • 97 Córdoba J, Gottstein J, Blei A T. Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis.  J Hepatol. 1998;  29 589-594
    CrossrefPubMedGoogle Scholar
  • 98 Restuccia T, Gomez-Anson B, Guevara M et al.. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis.  Hepatology. 2004;  39 1613-1622
    CrossrefPubMedGoogle Scholar
  • 99 Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure.  Hepatology. 2004;  39 464-470
    CrossrefPubMedGoogle Scholar
  • 100 Ginès P, Jimenez W. Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis.  J Hepatol. 1996;  24 506-512
    CrossrefPubMedGoogle Scholar
  • 101 Liu Q, Duan Z P, Ha D K, Bengmark S, Kurtovic J, Riordan S M. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.  Hepatology. 2004;  39 1441-1449
    CrossrefPubMedGoogle Scholar
  • 102 Chiva M, Soriano G, Rochat I et al.. Effect of lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis.  J Hepatol. 2002;  37 456-462
    CrossrefPubMedGoogle Scholar
  • 103 Hassanein T I, Tofteng F, Brown Jr R S et al.. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.  Hepatology. 2007;  46 1853-1862
    CrossrefPubMedGoogle Scholar

Juan CórdobaM.D. 

Servei de Medicina Interna-Hepatologia, Hospital Vall d'Hebron

Paseo Vall d'Hebron 119, Barcelona 08035, Spain

Email: jcordoba@vhebron.net

      >